4
Changes in Ownership
Organogenesis Holdings Inc. Filed Acc 0001062993-24-020285
President and CEO sold 59,468 shares at an average $3.56 ($211,721)
- President and CEO acquired 1,067,245 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gillheeney Gary S. President and CEO | 2024-12-05 | Option exercise | +1,067,245 | $0.99 | $1,056,573 | 3,419,194 | D |
| Gillheeney Gary S. President and CEO | 2024-12-06 | Sale | −18,416 | $3.65 | $67,218 | 3,400,778 | D |
| Gillheeney Gary S. President and CEO | 2024-12-09 | Sale | −41,052 | $3.52 | $144,503 | 3,359,726 | D |
| Derivatives | |||||||
| Gillheeney Gary S. President and CEO | 2024-12-05 | Option exercise · Stock Option (Right to Buy) | −1,067,245 | 0 | D | ||
| Open-market sales · 59,468 sh · avg $3.56 · $211,721 | |||||||
Loading xslF345X05/form4.xml…